PEDIATRIC CLINICAL TRIALS MARKET ANALYSIS

Pediatric Clinical Trials Market, by Clinical Trial Phase (Pre-clinical, Phase I, Phase II, and Phase III), by Study Design (Treatment Studies and Observational Studies), by Medical Condition (Neuropsychiatric Conditions, Infectious Diseases, Maternal and Perinatal Conditions, Respiratory Diseases, Cardiovascular Diseases, Cancer, Digestive Diseases and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Oct 2022
Code : CMI397
Pages :313
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges And Opportunities

Global Pediatric Clinical Trials Market: Restraint

The major factors that hinder growth of the global pediatric clinical trials market include high termination percentage of pediatric clinical trials due to several reasons. Pediatric trials have high percentage of failure due to reasons such as patient accrual. Other issues include behavioral problem and trial conduct issues such as inaccurate dosing, difficulty in formulation, and informative termination along with regulatory issues and drug toxicity during clinical trials.

Restraints & Challenges: